Biohaven Ltd. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BHVN New York 2834 www.biohaven.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biohaven Ltd.

Is Biohaven Ltd. (BHVN) Stock Outpacing Its Medical Peers This Year? - Feb 10th, 2026 7:40 am
Does Biohaven Ltd. (BHVN) Have the Potential to Rally 82.16% as Wall Street Analysts Expect? - Feb 9th, 2026 7:55 am
Here Are Friday’s Top Wall Street Analyst Research Calls: Amazon.com, Caterpillar, Estee Lauder, JPMorgan, Norfolk Southern, Roku, Snap, Vistra, and More - Feb 6th, 2026 6:07 am
Assessing Biohaven (BHVN) Valuation After A Sharp Momentum Rebound - Jan 23rd, 2026 3:09 am
Has Amneal Pharmaceuticals (AMRX) Outpaced Other Medical Stocks This Year? - Jan 22nd, 2026 7:40 am
Sector Update: Health Care Stocks Higher Late Afternoon - Jan 21st, 2026 1:54 pm
Biohaven Provides Updates on Several Clinical Programs; Shares Rise - Jan 12th, 2026 9:57 am
Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference - Jan 12th, 2026 9:15 am
Biohaven to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026 - Jan 7th, 2026 5:00 am
The Bull Case For Biohaven (BHVN) Could Change Following BHV-7000 MDD Trial Halt And R&D Pivot - Jan 4th, 2026 11:06 pm
These Stocks Are Moving the Most Today: Nvidia, Apple, Tesla, Coupang, Micron, Lam Research, Newmont, Moderna, and More - Dec 26th, 2025 12:14 pm
Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Friday as Market Reopens Following Holiday Break - Dec 26th, 2025 6:55 am
Biohaven Provides Update From Phase 2 Proof-of-Concept Study with BHV-7000 in Major Depressive Disorder - Dec 24th, 2025 11:00 am
Wall Street Analysts Predict an 88.57% Upside in Biohaven Ltd. (BHVN): Here's What You Should Know - Dec 24th, 2025 7:55 am
Biohaven (BHVN): Valuation Check After Encouraging BHV-1510 Immuno-Oncology Data at ESMO Congress - Dec 20th, 2025 8:09 am
Biohaven (BHVN) Is Down 5.9% After New BHV-1510 Combo Data - What's Changed - Dec 20th, 2025 2:12 am
Biohaven Ltd. (BHVN) Upgraded to Buy: Here's What You Should Know - Dec 19th, 2025 10:00 am
Biohaven Presents Clinical Safety and Efficacy Data for BHV-1510, a Next-Generation Trop2 Antibody Drug Conjugate in Combination with Cemiplimab at the 2025 European Society for Medical Oncology (ESMO) Immuno-Oncology Congress - Dec 11th, 2025 5:00 am
How Much Upside is Left in Biohaven Ltd. (BHVN)? Wall Street Analysts Think 127.52% - Dec 4th, 2025 7:55 am
Here Are Wednesday’s Top Wall Street Analyst Upgrades and Downgrades: American Eagle Outfitters, Equinix, Garmin, Honeywell, Uber, Wendy’s and More - Dec 3rd, 2025 7:15 am